| Zink, Barbara (Basilea 201109 Head Corporate Development) |
Business Development Manager / Strategy Manager |
Basilea (Group) |
Switzerland |
| Zinke, Holger (BRAIN 201507– Supervisory Board Member before CEO) |
Supervisory Board Member |
BRAIN Biotech (Group) |
Germany |
| Zinsser, Werner (Zinsser Analytic 200808 Managing Director) |
Managing Director |
KKR (Kohlberg Kravis Roberts) (Group) |
Germany |
| Zinsser-Noethen, Wiebke (Zinsser Analytic 200809) |
Sales Manager / Marketing Manager |
KKR (Kohlberg Kravis Roberts) (Group) |
Germany |
| Zinzalla, Vittoria (Boehringer 202402 Global Head of Oncology Translational Medicine + Clinical Pharmacology) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Zirngibl, Carmen (DCZ Executive Search 202312 + FS Life Science Investment) |
Managing Partner |
DCZ Executive Search GmbH |
Germany |
| Zitna , Andrea (Speedinvest 202212 Partner for Health Investments) |
Partner (venture partner) |
Speedinvest (Group) |
Austria |
| Ziwica, Marcel (Zur Rose Group 202007 CFO) |
Chief Financial Officer (CFO) |
Zur Rose Group (Group) |
Switzerland |
| Zobel, Peter Hanns (Bayern (govt) 1995–202403 Managing Director at IZB LEFT 3/24) |
Managing Director |
Bavaria (govt region) |
Germany |
| Zohar, Daphne (Seaport Therapeutics 202404– CEO + Co-Founder before PureTech Health CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Seaport Therapeutics (US) |
United States (USA) |
| Zolghadr, Kourosh (ChromoTek 201403 Head of RnD) |
Research & Development Manager |
Proteintech (Group) |
Germany |
| Zollner, Stanislava (Helmholtz 202008 at Ascenion GmbH) |
Public Relations Manager / Investor Relations Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
| Zoltobrocki, Manfred (PKCie 200604– Senior Consultant before Lux Biosciences GmbH + Epidaurus AG) |
Consultant (economic/technology) |
PKCie – Prof. Köpper & Cie Management Consultants GbR |
Germany |
| Zorbas, Haralabos (Bayern (govt) 201307 Managing Director of IBB Netzwerk GmbH) |
Managing Director |
Bavaria (govt region) |
Germany |
| Zori, Ron (Essential Capital 202311) |
Investment Manager |
Essential Capital (US, NY) |
United States (USA) |
| Zoro, Barney (Sartorius 201803 ambr Product Manager at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
| Zsebo, Krisztina (Celladon Corp 201411 CEO) |
Chief Executive Officer (CEO) |
Celladon Corporation |
United States (USA) |
| Zuber, Johannes (IMP Vienna 2011– Group Leader + Quantro Therapeutics 202007 Co-Founder + Scientific Advisor) |
Researcher (university / research institute) |
Boehringer Ingelheim (Group) |
Austria |
| Zucchelli, Piero (Andrew Alliance 201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Waters (Group) |
Switzerland |
| Zucker, Maximilian (Numares 201702 Executive Board Member + Head RnD) |
Board member, executive |
Numares (Group) |
Germany |
| Zuckerman, Linda (Evotec 202209 EVP Global Head Biotherapeutics at Just – Evotec Biologics) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
United States (USA) |
| Zuliani, Vincent (GenoSafe 201611 Business Development Director) |
Business Development Manager / Strategy Manager |
GenoSafe SAS |
France |
| Zumbansen, Markus (Ayoxxa 201407– VP RnD before Miltenyi Biotec) |
Research & Development Manager |
Ayoxxa (Group) |
Germany |
| Zumbrum, Michael (AllPure Technologies 201404 President) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
United States (USA) |
| Zundel, Stefan (Dopavision 201809– Managing Director + Co-Founder) |
Managing Director |
Dopavision GmbH |
Germany |
| zur Hausen, Harald |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| zur Hausen, Jan Dirk (Bergmann zur Hausen 201210 Managing Director + Co-founder) |
Managing Director |
Bergmann zur Hausen & Cie. GmbH |
Germany |
| Zurdo, Jesús (Rentschler 201911 SVP Innovation + Venture Partnerships) |
n. a. |
Rentschler (Group) |
Germany |
| Zurek Gabriela (Bruker Biosciences 2006 Bruker Daltonik GmbH Application Scientist) |
n. a. |
Bruker (Group) |
Germany |
| Zurlo, Alfredo (Glycotope 201604– CMO before Mologen 201304– CMO before Roche + EORTC) |
Chief Medical Officer (CMO) |
Glycotope (Group) |
Germany |
| Zwanziger, Ron (Alere/Inverness Medical 200603–201406 CEO RESIGNED 7/14) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United States (USA) |
| Zwick, Jordan (Mirador Therapeutics 202403 CBO formerly InflaRx before Salix + Medtronic) |
Business Development Manager / Strategy Manager |
Mirador Therapeutics Inc. |
United States (USA) |
| Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
Germany |
| Zwyer, Alex (NLS Pharmaceutics 202410 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NLS Pharmaceutics Ltd. (CH) (NLSP) |
Switzerland |
| Zündorf, Christin (TQ Therapeutics 202407 Business + Commercial) |
Business Development Manager / Strategy Manager |
TQ Therapeutics GmbH |
Germany |
| Zündorf, Peter (Schering 2005– before Aventis Pharma before RPR + Bayer) |
n. a. |
Bayer (Group) |
Germany |
| Zünkeler, Martin (Kairos GmbH 201203 Managing Director) |
Managing Director |
Iqvia (Group) |
Germany |
| Zypries, Brigitte (Germany (govt) 200809 Minister of Justice) |
Minister |
Germany (govt) |
Germany |
| Zywottek, Walter W. (Merck KGaA –200807 before VWR president and CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Zätzsch, Jörg (CMS Hasche Sigle 200809 Berlin) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Zöchbauer, Emmerich (BIA Separations 201509 Chair Board of BIA Separations Austria) |
Board member, executive |
Sartorius (Group) |
Austria |
| Zöllner, E. Jürgen (Stiftung Charité 201209 Board Member) |
n. a. |
Stiftung Charité |
Germany |
| Zörgiebel, Wilhelm (Willi) (Biotype Diagnostic 201107 Managing Director + Owner before Priontype) |
Managing Director |
Qiagen (Group) |
Germany |
| Åström, Håkan |
Board member |
Affibody Medical AB |
Sweden |
| Ölschläger, Uwe (Qiagen 200904) |
n. a. |
Qiagen (Group) |
Germany |
| Štrancar, Aleš (BIA Separations 201309 CEO + Chief Business Development Officer) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Slovenia |
| Šušteric, Jakob (MESI 202306 CEO) |
Chief Executive Officer (CEO) |
MESI (Group) |
Slovenia |
| Žmuc, Dora (Patronus Health 202204 Managing Director + Chief Business Development Officer + Co-Founder) |
Business Development Manager / Strategy Manager |
Patronus Health GmbH |
Germany |
| Ørnskov, Flemming (Shire 201301– CEO before Bayer Chief Marketing Officer + Bausch & Lomb + Ikaria + Novartis) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Ireland, Republic of |
| Ørum, Henrik (Santaris Pharma 200712 CSO + VP BusDev) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Denmark |
| Øystein, Soug (Polaris 201506 announced as CFO before Algeta + Orcla) |
Chief Financial Officer (CFO) |
Polaris (NO) (Group) |
Norway |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 93 94 95
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
